FEB 02, 2016 7:13 AM PST

First License to Genetically Edit Human Embryos Granted

WRITTEN BY: Xuan Pham
Embryonic development from single cell (top left) to blastocyst (bottom right).

In a historic, unprecedented move, UK national fertility regulators have given the green light for scientists to use the new CRISPR-cas9 gene-editing tool to manipulate human embryos. The approval stirred up big waves amongst the scientific community, as many leading nations are still observing a voluntarily moratorium to halt gene-editing in human embryonic cells.
 
 
Kathy NiakanThe research application, which was approved by the Human Fertilization and Embryology Authority (HFEA), outlined the use of CRISPR-cas9 to study how human embryonic development happens. Dr. Kathy Niakan leads this research endeavor. She explained that her research could help scientists better understand fertility and possibility solve infertility. 
 

We would really like to understand the genes needed for a human embryo to develop successfully into a healthy baby. The reason why it is so important is because miscarriages and infertility are extremely common, but they're not very well understood. – Dr. Niakan

There’s one major stipulation of the approval: the scientists cannot implant the edited embryos into any wombs, not that Dr. Niakan was planning to anyways. Her research will focus on the genetic changes in the embryos in the first several days of development. After seven days, the experiments will stop and the embryos will be destroyed.
 
This clause clearly stems from scientists’ uncertainties over the consequences of modifying human germ cells and early embryos. Unlike conventional gene therapies that target other cells in the body, gene editing in germ cells (sperm and egg) or early embryos has the potential to affect the genetics of future generations. That means genetic alterations could be passed on to children and even grandchildren. Because of the relative low cost and high efficiency of CRISPR/Cas9, gene manipulation in these precarious cells has never been easier. And this makes many people quite uneasy.
 
Some people applaud the landmark approval, noting that the decision struck a balance between scientific progress and ethical considerations.

Dr Niakan's proposed research is important for understanding how a healthy human embryo develops and will enhance our understanding of IVF success rates, by looking at the very earliest stage of human development. – Paul Nurse, the director of the Crick Institue.

"This decision is a victory for level-headed regulation over moral panic," added Sarah Norcross, director of the Progress Educational Trust.

Still, some think we may be dangerously close to crossing the line of unethical genetic manipulations.

So this is the first step in a well mapped-out process leading to GM babies, and a future of consumer eugenics. – Dr. David King, the director of Human Genetics Alert

How do you, readers, weigh in?

Sources: Nature News, New York Times, BBC
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
AUG 07, 2020
Cancer
Immune-Related Genes as Prognostic Biomarkers
AUG 07, 2020
Immune-Related Genes as Prognostic Biomarkers
Cancer is one of the most persistent and hardy diseases. Cancers often develop the ability to suppress the immune system ...
AUG 27, 2020
Clinical & Molecular DX
Genetic Tool Predicts Breast Cancer Risk in Women of Asian Ancestry
AUG 27, 2020
Genetic Tool Predicts Breast Cancer Risk in Women of Asian Ancestry
  Many diseases such as breast cancer have both a strong genetic component, coupled with a variety of environmental ...
SEP 21, 2020
Cancer
The Protein ETV1 May Act as a Biomarker for Gastrointestinal Cancer
SEP 21, 2020
The Protein ETV1 May Act as a Biomarker for Gastrointestinal Cancer
Cancer is an incredibly diverse disease. It has many types and even sub-types, with a vast range of characteristics. Som ...
SEP 25, 2020
Clinical & Molecular DX
Ray of Hope: Rare Cancer Biomarker Discovered
SEP 25, 2020
Ray of Hope: Rare Cancer Biomarker Discovered
Biliary tract cancer, or BTC, isn’t as talked about as breast or prostate cancers, probably because its incidence ...
OCT 02, 2020
Clinical & Molecular DX
Detecting Dystonia in the Blink of an AI
OCT 02, 2020
Detecting Dystonia in the Blink of an AI
A team of scientists have created a diagnostic tool, powered by artificial intelligence (AI), that can pick up on the su ...
NOV 18, 2020
Genetics & Genomics
Choosing an NGS workflow: What are you looking for?
NOV 18, 2020
Choosing an NGS workflow: What are you looking for?
  It’s easy to be overwhelmed by the number of workflows that are available for NGS. How do you choose? While ...
Loading Comments...